{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:17:35Z","timestamp":1785593855158,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071613269","type":"print"},{"value":"9781071613276","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/7651_2020_284","type":"book-chapter","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:03:10Z","timestamp":1591340590000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GMP-Compliant Adenoviral Vectors for Gene Therapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-5006","authenticated-orcid":false,"given":"Babak","family":"Arjmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Alavi-Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moloud","family":"Payab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Sheikh Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Tayanloo-Beik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"5","key":"284_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/gut.48.5.733","volume":"48","author":"LS Young","year":"2001","unstructured":"Young LS, Mautner V (2001) The promise and potential hazards of adenovirus gene therapy. Gut 48(5):733\u2013736","journal-title":"Gut"},{"issue":"3","key":"284_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0959-437X(93)90126-A","volume":"3","author":"KF Kozarsky","year":"1993","unstructured":"Kozarsky KF, Wilson JM (1993) Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3(3):499\u2013503","journal-title":"Curr Opin Genet Dev"},{"key":"284_CR3","unstructured":"Sleator A. (1997) The Human Genome Project, gene therapy and patenting: Great Britain, Parliament, House of Commons, Library"},{"key":"284_CR4","doi-asserted-by":"crossref","unstructured":"Rahim F, Arjmand B, Larijani B et al (2018) Stem cells treatment to combat cancer and genetic disease: from stem cell therapy to gene-editing correction. In: Van Pham P, El-Hashash A (eds) Stem Cells for Cancer and Genetic Disease Treatment, 1st edn. Springer Nature, Cham, Switzerland","DOI":"10.1007\/978-3-319-98065-2_3"},{"issue":"18","key":"284_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","volume":"334","author":"JM Wilson","year":"1996","unstructured":"Wilson JM (1996) Adenoviruses as gene-delivery vehicles. N Engl J Med 334(18):1185\u20131187","journal-title":"N Engl J Med"},{"key":"284_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27","journal-title":"Adv Biomed Res"},{"issue":"1","key":"284_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1634\/theoncologist.7-1-46","volume":"7","author":"SA Vorburger","year":"2002","unstructured":"Vorburger SA, Hunt KK (2002) Adenoviral gene therapy. Oncologist 7(1):46\u201359","journal-title":"Oncologist"},{"issue":"1","key":"284_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0163-7258(98)00020-5","volume":"80","author":"PD Robbins","year":"1998","unstructured":"Robbins PD, Ghivizzani SC (1998) Viral vectors for gene therapy. Pharmacol Ther 80(1):35\u201347","journal-title":"Pharmacol Ther"},{"key":"284_CR9","doi-asserted-by":"crossref","unstructured":"Cevher E, Sezer AD, \u00c7a\u011flar E (2012) Gene delivery systems: recent progress in viral and non-viral therapy. In: Demir Sezer A (ed) Recent advances in novel drug carrier systems, 1st edn. In Tech, Rijeka, Croatia","DOI":"10.5772\/53392"},{"issue":"1","key":"284_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1415-47572008000100001","volume":"31","author":"RS Coura","year":"2008","unstructured":"Coura RS, Nardi NB (2008) A role for adeno-associated viral vectors in gene therapy. Genet Mol Biol 31(1):1\u201311","journal-title":"Genet Mol Biol"},{"issue":"2","key":"284_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1566523024605591","volume":"2","author":"K Mitani","year":"2002","unstructured":"Mitani K, Kubo S (2002) Adenovirus as an integrating vector. Curr Gene Ther 2(2):135\u2013144","journal-title":"Curr Gene Ther"},{"issue":"6","key":"284_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2174\/156652305774964677","volume":"5","author":"JM Kaplan","year":"2005","unstructured":"Kaplan JM (2005) Adenovirus-based cancer gene therapy. Curr Gene Ther 5(6):595\u2013605","journal-title":"Curr Gene Ther"},{"issue":"5","key":"284_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nprot.2007.135","volume":"2","author":"J Luo","year":"2007","unstructured":"Luo J, Deng Z-L, Luo X et al (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2(5):1236","journal-title":"Nat Protoc"},{"issue":"3","key":"284_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3121\/cmr.4.3.218","volume":"4","author":"D Cross","year":"2006","unstructured":"Cross D, Burmester JK (2006) Gene therapy for cancer treatment: past, present and future. Clin Med Res 4(3):218\u2013227","journal-title":"Clin Med Res"},{"issue":"9","key":"284_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0167-7799(00)01475-X","volume":"18","author":"GN Ferreira","year":"2000","unstructured":"Ferreira GN, Monteiro GA, Prazeres DM et al (2000) Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol 18(9):380\u2013388","journal-title":"Trends Biotechnol"},{"issue":"2","key":"284_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K (2018) Viral vectors in gene therapy. Diseases 6(2):42","journal-title":"Diseases"},{"issue":"3","key":"284_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/hum.2005.16.281","volume":"16","author":"M Lusky","year":"2005","unstructured":"Lusky M (2005) Good manufacturing practice production of adenoviral vectors for clinical trials. Hum Gene Ther 16(3):281\u2013291","journal-title":"Hum Gene Ther"},{"issue":"2","key":"284_CR18","first-page":"42","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K (2018) Viral vectors in gene therapy. Diseases (Basel, Switzerland) 6(2):42","journal-title":"Diseases (Basel, Switzerland)"},{"issue":"4","key":"284_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/hum.2014.007","volume":"25","author":"J Vellinga","year":"2014","unstructured":"Vellinga J, Smith JP, Lipiec A et al (2014) Challenges in manufacturing adenoviral vectors for global vaccine product deployment. Hum Gene Ther 25(4):318\u2013327","journal-title":"Hum Gene Ther"},{"key":"284_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-319-46410-7_10","volume-title":"Perinatal tissue-derived stem cells: alternative sources of fetal stem cells","author":"HR Aghayan","year":"2016","unstructured":"Aghayan HR, Arjmand B, Burger SR (2016) GMP facilities for clinical cell therapy product manufacturing: a brief review of requirements and design considerations. In: Arjmand B (ed) Perinatal tissue-derived stem cells: alternative sources of fetal stem cells. Springer, Cham, pp 215\u2013227"},{"issue":"4","key":"284_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5312\/wjo.v5.i4.402","volume":"5","author":"P Carpintero","year":"2014","unstructured":"Carpintero P, Caeiro JR, Carpintero R et al (2014) Complications of hip fractures: a review. World J Orthop 5(4):402\u2013411","journal-title":"World J Orthop"},{"key":"284_CR22","doi-asserted-by":"crossref","unstructured":"Goodarzi P, Falahzadeh K, Aghayan H et al (2018) GMP-compliant human fetal skin fibroblasts for wound healing. Arch Neurosci 5(3):e68497","DOI":"10.5812\/ans.68497"},{"issue":"9","key":"284_CR23","first-page":"540","volume":"53","author":"B Larijani","year":"2015","unstructured":"Larijani B, Aghayan H, Goodarzi P et al (2015) Clinical grade human adipose tissue-derived mesenchymal stem cell banking. Acta Med Iran 53(9):540\u2013546","journal-title":"Acta Med Iran"},{"issue":"4","key":"284_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10561-011-9273-1","volume":"13","author":"B Larijani","year":"2012","unstructured":"Larijani B, Arjmand B, Amoli MM et al (2012) Establishing a cGMP pancreatic islet processing facility: the first experience in Iran. Cell Tissue Bank 13(4):569\u2013575","journal-title":"Cell Tissue Bank"},{"key":"284_CR25","unstructured":"Dubbs JH (1903) History of Franklin and Marshall College: Franklin College, 1787\u20131853; Marshall College, 1836\u20131853; Franklin and Marshall College, 1853\u20131903. Franklin and Marshall College Alumni Association"},{"key":"284_CR26","doi-asserted-by":"crossref","unstructured":"Akyar I (2012) Standard operating procedures (what are they good for?). In: Akyar I (ed) Latest research into quality control, 1st edn. In Tech, Rijeka, Croatia","DOI":"10.5772\/50439"},{"issue":"9","key":"284_CR27","doi-asserted-by":"publisher","first-page":"e0138760","DOI":"10.1371\/journal.pone.0138760","volume":"10","author":"A Yakimovich","year":"2015","unstructured":"Yakimovich A, Andriasyan V, Witte R et al (2015) Plaque2.0\u2014a high-throughput analysis framework to score virus-cell transmission and clonal cell expansion. PLoS One 10(9):e0138760","journal-title":"PLoS One"},{"issue":"9","key":"284_CR28","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1128\/JVI.79.9.5437-5444.2005","volume":"79","author":"GJ Duigou","year":"2005","unstructured":"Duigou GJ, Young CSH (2005) Replication-competent adenovirus formation in 293 cells: the recombination-based rate is influenced by structure and location of the transgene cassette and not increased by overproduction of HsRad51, Rad51-interacting, or E2F family proteins. J Virol 79(9):5437\u20135444","journal-title":"J Virol"},{"issue":"12","key":"284_CR29","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.vaccine.2006.12.011","volume":"25","author":"G Marzio","year":"2007","unstructured":"Marzio G, Kerkvliet E, Bogaards JA et al (2007) A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. Vaccine 25(12):2228\u20132237","journal-title":"Vaccine"}],"container-title":["Methods in Molecular Biology","Stem Cells and Good Manufacturing Practices"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7651_2020_284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T20:10:49Z","timestamp":1617221449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7651_2020_284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071613269","9781071613276"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/7651_2020_284","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"6 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}